Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11451 - 11475 of 11850 in total
PF-06291874 is under investigation in clinical trial NCT02175121 (Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of PF-06291874 as Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus).
Investigational
Matched Description: … PF-06291874 is under investigation in clinical trial NCT02175121 (Safety, Tolerability, Pharmacokinetics …
G305 is a recombinant NY-ESO-1 protein plus glucopyranosyl lipid A (GLA) in a stable emulsion (SE). G305 is an active component of CMB305 along with LV305.
Investigational
Matched Description: … G305 is a [recombinant NY-ESO-1 protein] plus glucopyranosyl lipid A (GLA) in a stable emulsion (SE). …
Pazufloxacin is under investigation in clinical trial NCT02592096 (Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol).
Investigational
Matched Description: … Pazufloxacin is under investigation in clinical trial NCT02592096 (Pazufloxacin Mesilate Ear Drops Clinical …
ASP4058 has been used in trials studying Food Effect of ASP4058 and Pharmacokinetics of ASP4058.
Investigational
Matched Description: … ASP4058 has been used in trials studying Food Effect of ASP4058 and Pharmacokinetics of ASP4058. …
Pritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes.
Investigational
Matched Description: … Pritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes. …
Ipa has been used in trials studying the treatment of Nausea and Surgical Site Infection.
Investigational
Matched Description: … Ipa has been used in trials studying the treatment of Nausea and Surgical Site Infection. …
AZD4818 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease (COPD).
Investigational
Matched Description: … AZD4818 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease (COPD …
Fosdagrocorat has been used in trials studying the treatment and basic science of Rheumatoid Arthritis.
Investigational
Matched Description: … Fosdagrocorat has been used in trials studying the treatment and basic science of Rheumatoid Arthritis …
TRV120027 has been used in trials studying the treatment of Heart Failure and Kidney Disease.
Investigational
Matched Description: … TRV120027 has been used in trials studying the treatment of Heart Failure and Kidney Disease. …
Fezakinumab has been used in trials studying the treatment of Atopic Dermatitis and Rheumatoid Arthritis.
Investigational
Matched Description: … Fezakinumab has been used in trials studying the treatment of Atopic Dermatitis and Rheumatoid Arthritis …
Bitopertin has been used in trials studying the treatment of Schizophrenia and Obsessive-Compulsive Disorder.
Investigational
Matched Description: … Bitopertin has been used in trials studying the treatment of Schizophrenia and Obsessive-Compulsive Disorder …
Bioperine has been used in trials studying the treatment of Multiple Myeloma and Deglutition Disorders.
Investigational
Matched Description: … Bioperine has been used in trials studying the treatment of Multiple Myeloma and Deglutition Disorders …
AZD9056 has been used in trials studying the basic science and treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … AZD9056 has been used in trials studying the basic science and treatment of Rheumatoid Arthritis. …
UK-432,097 has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.
Investigational
Matched Description: … UK-432,097 has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive. …
Nivocasan has been used in trials studying the treatment of HCV Infection and Nonalcoholic Steatohepatitis.
Investigational
Matched Description: … Nivocasan has been used in trials studying the treatment of HCV Infection and Nonalcoholic Steatohepatitis …
Atreleuton has been used in trials studying the treatment of Atherosclerosis and Coronary Artery Disease.
Investigational
Matched Description: … Atreleuton has been used in trials studying the treatment of Atherosclerosis and Coronary Artery Disease …
Glial growth factor 2 has been used in trials studying the treatment of Heart Failure.
Investigational
Matched Description: … Glial growth factor 2 has been used in trials studying the treatment of Heart Failure. …
Pactimibe has been used in trials studying the treatment of Atherosclerosis and Coronary Heart Disease.
Investigational
Matched Description: … Pactimibe has been used in trials studying the treatment of Atherosclerosis and Coronary Heart Disease …
Berkelium is under investigation in clinical trial NCT02189122 (Comparative Effects of Aspirin and NHP-544C).
Investigational
Matched Description: … Berkelium is under investigation in clinical trial NCT02189122 (Comparative Effects of Aspirin and NHP …
Thioureidobutyronitrile has been used in trials studying the treatment of Solid Tumors and Ovarian cancer.
Investigational
Matched Description: … Thioureidobutyronitrile has been used in trials studying the treatment of Solid Tumors and Ovarian cancer …
Gossypol has been used in trials studying the treatment of Non-small Cell Lung Cancer.
Investigational
Matched Description: … Gossypol has been used in trials studying the treatment of Non-small Cell Lung Cancer. …
Pruvanserin has been used in trials studying the treatment of Sleep Initiation and Maintenance Disorders.
Investigational
Matched Description: … Pruvanserin has been used in trials studying the treatment of Sleep Initiation and Maintenance Disorders …
Human coagulation factor IX (EC 3.4.21.22, Christmas factor, plasma thromboplastin component), produced in CHO cells.
Investigational
Matched Description: … Human coagulation factor IX (EC 3.4.21.22, Christmas factor, plasma thromboplastin component), produced in
Tarloxotinib is under investigation in clinical trial NCT03743350 (NSCLC Exon 20 or HER2-activating Mutations).
Investigational
Matched Description: … Tarloxotinib is under investigation in clinical trial NCT03743350 (NSCLC Exon 20 or HER2-activating Mutations …
beta-Alanine is an amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported.
Experimental
Matched Description: … beta-Alanine is an amino acid formed in vivo by the degradation of [dihydrouracil] and [carnosine]. …
Displaying drugs 11451 - 11475 of 11850 in total